Compass Therapeutics, Inc. (CMPX)
0.6882
+0.01
(+1.43%)
USD |
NASDAQ |
Nov 20, 16:00
0.6834
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Price to Book Value : 0.8693 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.8693 |
| November 19, 2026 | 0.857 |
| November 18, 2026 | 0.7718 |
| November 17, 2026 | 0.7664 |
| November 16, 2026 | 0.8356 |
| November 13, 2026 | 0.9774 |
| November 12, 2026 | 1.036 |
| November 11, 2026 | 1.049 |
| November 10, 2026 | 1.058 |
| November 09, 2026 | 1.057 |
| November 06, 2026 | 0.9585 |
| November 05, 2026 | 0.8648 |
| November 04, 2026 | 0.9634 |
| November 03, 2026 | 0.9512 |
| November 02, 2026 | 0.9695 |
| October 30, 2026 | 0.9935 |
| October 29, 2026 | 0.9552 |
| October 28, 2026 | 0.9604 |
| October 27, 2026 | 0.9441 |
| October 26, 2026 | 0.9438 |
| October 23, 2026 | 0.9613 |
| October 22, 2026 | 1.012 |
| October 21, 2026 | 1.029 |
| October 20, 2026 | 1.053 |
| October 19, 2026 | 1.055 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.086 |
| October 15, 2026 | 1.133 |
| October 14, 2026 | 1.110 |
| October 13, 2026 | 1.082 |
| October 12, 2026 | 1.184 |
| October 09, 2026 | 1.254 |
| October 08, 2026 | 1.242 |
| October 07, 2026 | 1.288 |
| October 06, 2026 | 1.261 |
| October 05, 2026 | 1.213 |
| October 02, 2026 | 1.082 |
| October 01, 2026 | 1.138 |
| September 30, 2026 | 1.314 |
| September 29, 2026 | 1.193 |
| September 28, 2026 | 1.204 |
| September 25, 2026 | 1.226 |
| September 24, 2026 | 1.231 |
| September 23, 2026 | 1.269 |
| September 22, 2026 | 1.345 |
| September 21, 2026 | 1.974 |
| September 18, 2026 | 2.061 |
| September 17, 2026 | 2.006 |
| September 16, 2026 | 1.985 |
| September 15, 2026 | 2.006 |
| September 14, 2026 | 2.126 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viking Therapeutics, Inc. | 5.366 |
| Capricor Therapeutics, Inc. | 2.104 |
| Ardelyx, Inc. | 4.575 |
| Biomea Fusion, Inc. | 5.503 |
| ARS Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PEG Ratio | -1.152 |
| Price | 0.6882 |
| Earnings Yield | -67.35% |
| Market Cap | 123.94M |
| PEGY Ratio | -1.152 |